LENZ   $27.99  6.34% Market Closed After Close 27.99 0.0

LENZ Therapeutics Inc

Current temperature: 0.00
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 6
Target Price Mean 34
Mean unverified/preliminary 34 / 34
Target Price Low / High 31 / 38
Median / STD DEV 34 / 3.01
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell Sell Sell
macd None Sell None
stoch Sell None None
ma20 Sell Sell Sell
ma50 None None None
ma100 None None Sell
Candlestick PatternSept. 25, 2024 Gravestone - is formed when the opening and closing prices are at the lowest of the day. If it has a longer upper shadow it signals a bearish trend. When it appears at market top it is considered a reversal signal.
ISIN US52635N1037
ceo Mr. Evert B. Schimmelpennink
Website https://www.lenz-tx.com
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.